Abstract α-Synuclein (αSyn) is the main component of Lewy bodies formed in midbrain dopaminergic neurons which is a pathological characteristic of Parkinson's disease. It has been recently showed to induce endoplasmic reticulum (ER) stress and impair ER functions. However, the mechanism of how ER responds to αSyn toxicity is poorly understood. In the present study, we found that protein disulfide isomerase (PDI), a stress protein abundant in ER, effectively inhibits αSyn fibril formation in vitro. In PDI molecule with a structure of abb'xa'c, domain a' was found to be essential and sufficient for PDI to inhibit αSyn fibril formation. PDI was further found to be more avid for binding with intermediate species formed during αSyn fibril formation, and the binding was more intensive in the later lag phase. Our results provide new insight into the role of PDI in protecting ER from the deleterious effects of misfolded protein accumulation in many neurodegenerative diseases.
Introduction
Parkinson's disease (PD), the second most common neurodegenerative disease, has two prominent pathological characteristics: progressive dopaminergic neuronal loss and the presence of Lewy bodies which consist mainly of α-Synuclein (αSyn); (Polymeropoulos et al. 1997; Spillantini et al. 1998) . Some cases of early familial PD were identified as being linked to three αSyn mutations, namely A53T, A30P, and E46K (Kruger et al. 1998; Munoz et al. 1997; Zarranz et al. 2004) , these mutations accelerate the fibrillation or oligomerization of the mutated proteins in vitro (Conway et al. 2000) . Overexpression of αSyn in flies (Feany and Bender 2000) , mice (Masliah et al. 2000) , and primates (Kirik et al. 2003 ) is sufficient to trigger PD, suggesting the important roles αSyn fibrillation plays in the disease pathogenesis.
αSyn, initially identified as a synaptic vesicle-associated protein, is also found in the cytosol and nucleus (Kontopoulos et al. 2006; Lee et al. 2005) . In immunogold electron microscopy examination of rat brain neurons, the αSyn concentration was found to be higher in endoplasmic reticulum (ER) than in cytoplasmic region (Zhang et al. 2008) . Synthesized αSyn in yeast was found to be translocated from the ER to the Golgi and further to the plasma membrane through a classical secretion pathway (Dixon et al. 2005) . Recently, αSyn has been reported to be involved in the impairment of ER functions. Overexpression of αSyn A53T mutant in differentiated PC12 cells induces ER stress (Smith et al. 2005) , and overexpression of wild-type αSyn or the A53T mutant in yeast induces unfolded protein response and blocks ER-Golgi trafficking (Cooper et al. 2006; Gitler et al. 2008) .
Protein disulfide isomerase (PDI) is a multifunctional stress protein abundant in ER with both isomerase and chaperone activities (Yao et al. 1997) . It facilitates the folding, unfolding, and translocation of many proteins (Ellgaard and Ruddock 2005; Papp et al. 2003 ) and protects ER from damage. PDI is an essential protein, and is expressed in nearly all tissues, including neural tissue and various cultured neural cell lines (www.proteinatlas.org). PDI can prevent neurotoxicity associated with ER stress and protein misfolding, whereas S-nitrosylation of PDI suppresses this protective effect in PD or Alzheimer's disease (Uehara et al. 2006) . However, the interactions of PDI and αSyn have not yet been reported so far to the best of our knowledge.
In our experiments, we examined how PDI affected αSyn fibril formation and found out for the first time that PDI can effectively inhibit αSyn fibril formation in vitro, very likely via interacting with αSyn intermediates formed during the course. And we also identified the a' domain of PDI as crucial to PDI's ability of inhibiting αSyn fibril formation.
Materials and methods

Protein expression and purification
The PCR products of the a and a'c fragments amplified from pQE30-PDI were ligated into pQE30 with BamHI/ HindIII sites to construct corresponding expression plasmids. The coding sequence of DsbCn-a'c was constructed by overlapping PCR products amplified from pQE30-PDI and pQE60-DsbC, respectively, and the gene fusion digested with BamHI/HindIII was then ligated into pQE30. Full-length human PDI, PDI fragments (PDI (1-462), abb'x, bb'xa', a, and a'c), DsbC, and DsbCn-a'c were expressed in Escherichia coli M15 [REP4] with a Nterminal His tag (MRGSHHHHHHGS) and purified by using a nickel-nitrilotriacetic acid column as described previously (Wang et al. 2009 ). Recombinant human αSyn was expressed in BL21 (DE3) and was purified by chromatography of the supernatant after osmotic shock on a Q-Sepharose fast-flow column as described previously (Huang et al. 2005) . Concentration of αSyn was determined spectrophotometrically by using the absorption coefficient A 0:1% 280 of 0.354 or by the bicinchoninic acid method with bovine serum albumin (BSA) as a standard. The concentrations of PDI and domain combinations were determined by Bradford assay with BSA as a standard.
Determination of αSyn fibril formation by Thioflavin T fluorescence
The kinetics of fibril formation of αSyn was monitored using Thioflavin T (ThT) binding fluorescence as described (Huang et al. 2006) . Briefly, αSyn solution at 70 μM in buffer A (50 mM Tris-HCl, 0.2 M NaCl, 0.05% NaN 3 (w/v), pH 8.0) with or without different concentrations of PDI proteins were incubated with shaking at 37°C. An aliquot of 8-μl reaction mixture was taken at time intervals for ThT fluorescence measurement.
Electron microscopy
A 5-μl aliquot was taken from the aggregation reaction mixture at 48 h of fibril formation, adsorbed onto a glowdischarged carbon support film, washed twice using 20 μl distilled water, and negatively stained with 2% (w/v) uranyl acetate. Micrographs were recorded on Gatan Digital Micrograph at ×14,500 magnification on a Philp Tecnai 20 electron microscope.
Protein interaction characterization by gel filtration
Prefibrillar αSyn was prepared as described by Volles et al. (Volles et al. 2001) i.e. a concentrated αSyn solution at 1-2 mM in buffer B (buffer A supplemented with 10 mM 2-mercaptoethanol) was eluted on a Superdex 200 10/300 GL column (Amershan Phamacia Biotech) at 0.5 ml/min, and the protein in the void peak was collected as prefibrillar αSyn. An 800 μl solution of 5 μM prefibrillar αSyn (monomer concentration) or 10 μM αSyn in buffer B was incubated with or without 10 μM PDI proteins at room temperature for 2 h and eluted on the same column, and the elution peaks were collected, precipitated by acetone at -20°C, and analyzed by 15% SDS-PAGE.
Isothermal titration calorimetry measurement
Thermodynamic parameters associated with interactions between PDI proteins and αSyn were measured on a VPisothermal titration calorimetry (ITC) titration calorimeter (MicroCal, Inc.) at 25°C. At 0, 3, 6, and 48 h of αSyn fibril formation, reaction samples were taken and diluted to 30 µM (αSyn monomer concentration) and loaded into the sample cell, and a solution of 300 µM PDI proteins was placed in the injection syringe. The first injection of 5 µl was followed by 29 injections of 10 µl. The PDI proteins were injected into buffer alone, and the dilution heats were measured and subtracted from the experiment data prior to data analysis. Data were analyzed using MicroCal ORIGIN software supplied with the instrument. All experiments were performed in buffer C (25 mM TrisHCl, 0.1 M NaCl, 0.05% NaN 3 (w/v), pH 8.0). The stirring rate was 300 rpm.
Statistics
Data were expressed as mean ± standard deviation (SD). Differences among means were analyzed by using unpaired one-tailed or two-tailed t test. A p value of 0.05 or less was judged to be significant.
Results
PDI suppresses αSyn fibril formation
Under the established conditions, the αSyn fibril formation monitored by using ThT fluorescence in 1-2 days showed a sigmoid growth curve, which included an initial lag phase, a subsequent exponential growth phase, and a final equilibrium phase (Fig. 1a) . When the molar ratio of PDI to αSyn was 0.1, the increase in ThT fluorescence observed in the absence of PDI was inhibited by~75%, and PDI with higher molar ratios against αSyn, e.g., 0.2 and 0.5, showed only little further effects (Fig. 1b) . PDI itself showed little ThT fluorescence over the experiment course (Fig. 1a) . BSA, a protein with no chaperone activity but a molecular weight similar to that of PDI, was used as a negative control because it did not inhibit αSyn fibril formation (Fig. 1a) . Yeast prion protein Ure2p also forms fibril in vitro, and this process was reportedly inhibited by Ssa1p (Savistchenko et al. 2008) , the yeast homolog of human Hsp70, another potent inhibitor of αSyn fibril formation (Dedmon et al. 2005; Huang et al. 2006 ). However, we observed that PDI, unlike Hsp70, did not inhibit the fibril formation of Ure2p (data not shown), suggesting that PDI interacts with αSyn specifically to inhibit its fibril formation. Figure 1c shows the electron microscopy images of the morphology of αSyn aggregates formed at the equilibrium phase. When αSyn was incubated alone, it formed long tangled fibrils which were micrometers long and~10 nm in diameter. In the presence of PDI there were only amorphous αSyn aggregates instead of fibrils. In the presence of BSA, αSyn still formed long tangled fibrils.
Effects of PDI domains on αSyn fibril formation PDI comprises four thioredoxin (Trx) domains: two catalytic domains, a and a', separated by two noncatalytic domains, b and b', followed by a C-terminal region c. In addition, there is a short linker region "x" situated between the b' and a' domains. The b' domain of PDI has been identified as the primary site for binding short peptides to PDI and essential for binding more complex substrates to PDI while the a and a' domains of PDI contribute to binding large substrates to PDI (Klappa et al. 1998; Pirneskoski et al. 2004) .
For the purpose of locating the part of PDI molecule which is responsible for its ability of inhibiting αSyn fibril formation, we constructed several PDI domain combinations (Fig. 2a) . As shown in Fig. 2b and c, PDI (1-462) , i.e., the PDI with the c region removed, inhibited αSyn fibril formation to a similar extent as full-length PDI did, indicating that the c region of PDI is not required in inhibiting αSyn fibril formation. The abb'x fragment, with both domain a' and c region removed from full-length PDI, showed much weaker inhibiting effect, i.e., it inhibited onlỹ 40% of αSyn fibril formation; while the bb'xa' fragment containing domain a' inhibited αSyn fibril formation to the same extent as full-length PDI did. This suggests that domain a' is required for inhibiting αSyn fibril formation. We further examined the inhibiting ability of fragment a'c (which was used instead of domain a' alone because of its Fig. 1 Inhibition of αSyn fibril formation by PDI. a The experiments of fibril formation of 70 μM αSyn in the absence (filled square)/ presence of 35 μM PDI (filled triangle) or BSA (filled circle) and fibril formation of PDI alone (filled diamond) were carried out as described in the text, and ThT fluorescence at 482 nm were measured at different time points as indicated and normalized. b Fibril formation of 70 μM αSyn in the presence of PDI at various molar ratios were assessed with respect to ThT fluorescence at 48 h. Data are expressed as mean ± SD (*p<0.05, ***p<0.001 by unpaired one-tailed t test (n≥4)). c Electron micrographs of 70 μM αSyn fibril formation at 48 h in the equilibrium phase in the absence and presence of 35 μM PDI or BSA. Scale bar 200 nm much better solubility and the c region being negligible in inhibiting αSyn fibril formation). It was observed that fragment a'c alone did inhibit αSyn fibril formation as effectively as full-length PDI did. Although domains a and a' share 36.8% identity with each other, domain a showed no effect on αSyn fibril formation. We further designed a domain chimera DsbCn-a'c by replacing the C-terminal Trx domain of E. coli DsbC with domain a'c of PDI to further examine the effect of a'c. DsbC locates in the periplasm of prokaryotic cells, and is a prokaryotic counterpart of PDI in the ER of eukaryotic cells, but shows no (Huang et al. 2006) or weak inhibiting effect on αSyn fibril formation (Fig. 2b and c) . DsbC is a homodimeric protein, and each subunit consists of a C-terminal Trx domain and an Nterminal domain for dimerization. Just as we anticipated, the chimera DsbCn-a'c, compared to wild-type DsbC, was much more efficient in inhibiting αSyn fibril formation (p< 0.001; Fig. 2b and c) . All the above data provide strong evidence that domain a' plays a key role in inhibiting αSyn fibril formation.
Interactions of PDI with intermediate species formed during αSyn fibril formation
The PDI's ability to inhibit αSyn fibril formation indicates the interactions between PDI and αSyn or αSyn intermediate species formed during fibril formation. Firstly we used gel filtration to probe the interaction complexes of PDI and various αSyn species. The incubated mixture of native αSyn and PDI showed only two elution peaks, the positions of which were identical with those of the elution peaks of separately incubated αSyn and PDI, indicating that there is no interaction between αSyn and PDI (data not shown). Artificial prefibrillar αSyn, which was prepared to mimic the intermediate species of αSyn formed in the lag phase, was eluted at a void volume of about 8 ml in a broad peak well separated from the peaks of monomeric αSyn at 13.9 ml and PDI at 12.9 ml. Compared with the prefibrillar αSyn incubated alone, the incubated mixture of PDI and prefibrillar αSyn showed a slightly enlarged void peak (Fig. 3a) . SDS-PAGE analysis of the collected void peak showed not only the αSyn band with an apparent molecular mass of 18 kDa but also a band of 57 kDa for PDI (Fig. 3b) , indicating the interaction and complex formation between PDI and prefibrillar αSyn. The void peak area of the incubated prefibrillar αSyn with abb'x remained unchanged, but that of the incubated prefibrillar αSyn with bb'xa' (Fig. 3a) grew larger. The SDS-PAGE analysis of corresponding void volume collections also showed prefibrillar αSyn binding with bb'xa' but not abb'x (Fig. 3b) . The above results showed that PDI interacted with prefibrillar αSyn but not native αSyn, and that bb'xa', not abb'x, interacted with prefibrillar αSyn, indicating that the a' domain is responsible for the interactions between PDI and prefibrillar αSyn.
ITC can directly detect the heat changes during proteinprotein interaction, and the analysis of the reaction heat as a Fig. 2 Inhibition of αSyn fibril formation by PDI domains. a Schematic representation of domain structure of PDI molecule and domain combinations. b Fibril formation of 70 μM αSyn in the absence (filled square) and presence of 35 μM PDI (unfilled inverted triangle), PDI (1-462; unfilled square), abb'x (filled triangle), bb'xa' (unfilled triangle), a (filled diamond), a'c (unfilled diamond), DsbC (filled circle), and DsbCn-a'c (unfilled circle) were measured at various time points (b) or at 48 h (c) as indicated by using ThT fluorescence at 482 nm and the measured data were normalized. The data in c were expressed as mean ± SD (*p<0.05, ***p<0.001 by unpaired one-tailed t test (n≥4)) function of protein concentration provides complete characterization of the thermodynamic properties of proteinprotein interactions (Velazquez-Campoy et al. 2004) . Thus, ITC was adopted to measure the extent of the interactions between PDI and αSyn in this study. The calorimetric data of the interaction between PDI and 0 h αSyn sample were too small to be fitted into any binding model, indicating no specific binding affinity of PDI to αSyn monomer. The integrated binding isotherms of the samples at 3 and 6 h in the lag phase and at 48 h in the final equilibrium phase fitted a three sequential binding sites model best (Fig. 3c) . Since the second and the third binding events might reflect nonspecific weak interactions corresponding to a multi-site low affinity binding of substrates to PDI (Gruber et al. 2006) , we only used the first binding parameters for comparison. The interaction between PDI and αSyn intermediate species formed at 3 h was weak with a dissociation constant of 20.9 μM, and the interaction between PDI and αSyn intermediate species formed at 6 h increased significantly with a dissociation constant of 2.8 μM, suggesting PDI was more avid for binding with the intermediate species in the later lag phase. PDI was also observed to be bound with fibril formed at 48 h with a dissociation constant of 1.2 μM. To sum up, the above results indicate that PDI preferentially binds with αSyn intermediate species since the early stages of the assembly, inhibiting the progress of fibril formation.
Discussion
The major findings of this study are that PDI is able to inhibit αSyn fibril formation and domain a' of PDI plays a key role in this process. This suggests that the role of domain a' in the interactions between PDI and misfolded proteins has been underestimated. Our study also showed that PDI binds with intermediate species in the αSyn fibril formation process to inhibit the fibril formation. Fig. 3 Interactions between PDI or its domain combinations and αSyn intermediates. a Chromatography profiles of incubations of prefibrillar αSyn without (solid) and with PDI (dashed), abb'x (dotted), or bb'xa' (dash-dotted) on a Superdex 200 10/300 GL column. b SDS-15%PAGE of void fractions in (a). Lane 1 molecular mass markers, lane 2 prefibrillar αSyn, lanes 3-5 co-incubation of prefibrillar αSyn and PDI, abb'x, or bb'xa', respectively. c ITC data of binding of the PDI proteins to αSyn at 25°C: squares represent the integrated binding isotherm at each injection after dilution heat effect correction and molar concentration based normalization, solid lines represent the non-linear least squares fit to a three sequential binding sites model, and the best fit parameters of dissociation constant K d for the first binding event are indicated therein αSyn has recently been shown to be implicated in ER impairment and ER stress (Wang and Takahashi 2007) , however, the mechanism remains unknown. It was found that αSyn is more concentrated in ER than in cytoplasmic region (Zhang et al. 2008) . Our data provide direct evidence for the interactions between αSyn and PDI, and suggest that PDI, a key component of the protein quality control system in the ER, may counteract the toxicity of αSyn in the ER by binding oligomeric αSyn formed in the early stage and finally inhibiting fibril formation.
PDI can also function in non-ER locations including the cell surface, the extracellular space, the cytosol, and the nucleus (Turano et al. 2002) . PDI was shown to co-localize with cytoplasmic aggregates formed by Cu/Zn-superoxide dismutase or its mutants in animal and cell model of familial amyotrophic lateral sclerosis (Atkin et al. 2006 ). Co-expression of PDI with synphilin-1 in cultured SH-SY5Y cells greatly decreased discrete Lewy-body-like inclusions formed by synphilin-1 in the cytoplasm; and Snitrosylation of PDI by nitric oxide attenuated this inhibiting effect (Uehara et al. 2006) . Moreover, by means of immunohistochemistry, pancreatic PDI was shown to colocalize with αSyn in Lewy bodies in the postmortem human brain tissue from patients with Dementia with Lewy bodies (Conn et al. 2004 ). Hence, PDI may function in the cytoplasm to play protective roles against αSyn cytotoxicity.
Our study on the interaction between αSyn and PDI suggests a new cellular defense mechanism against αSyn toxicity and a new path in developing therapies against neurodegenerative diseases associated with abnormal protein accumulation. Further studies are required to examine this defense mechanism in detail on the cell and animal level.
